Particle Works’ game-changing particle engineering platforms are set to revolutionise the way customers discover, develop and scale-up particle production for a wide range of applications. The brand draws on Blacktrace Holdings’ 20+ years of experience in particle engineering and microfluidic technology to offer novel systems for the consistent and reliable generation of various particle types for use in the medical, biotechnology and materials science industries.
Previously, nanoparticles – such as liposomes, lipid nanoparticles (LNPs) and polymer-based nanoparticles – have been produced using batch methods that are inconsistent and difficult to control, risking damage to encapsulated products and leading to polydisperse particles to produce variable in vivo results. Particle Works will solve this challenge by using proven and reliable microfluidic technologies to create pioneering systems capable of consistent and tuneable particle generation. This will enable the manufacturing process to be more stable and efficient, with a lower chance of particle damage, ...
